Vertex Pharmaceuticals (VRTX) Asset Utilization Ratio (2010 - 2026)

Vertex Pharmaceuticals' Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.47 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 4.1% year-over-year to 0.47 in Q1 2026; TTM through Mar 2026 was 0.47, a 4.1% decrease from a year earlier, with the FY2025 full-year figure at 0.5, up 2.32% from the prior year.
• Asset Utilization Ratio fell to 0.47 in Q1 2026 per VRTX's latest filing, from 0.48 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.57 in Q1 2022 and bottomed at 0.44 in Q1 2024.
• The 5-year median for Asset Utilization Ratio is 0.49 (2025), against an average of 0.49.
• Across the five-year window, Asset Utilization Ratio declined 14.85% in 2023 and advanced 11.94% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.51 in 2022, then retreated by 13.35% to 0.44 in 2023, then climbed by 10.87% to 0.49 in 2024, then fell by 3.46% to 0.48 in 2025, then dropped by 1.36% to 0.47 in 2026.
• Per Business Quant, the three latest VRTX Asset Utilization Ratio figures stand at 0.47 (Q1 2026), 0.48 (Q4 2025), and 0.48 (Q3 2025).